Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 60687-758

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 60687-758). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 mg Lurasidone Hydrochloride Tablet Blister (20 mg Blister)

Lurasidone Hydrochloride 20 mg film-coated tablet labels for oral use. Each label includes the proprietary and generic name, strength of 20 mg, lot number and expiry placeholders, barcodes, and American Health Packaging as the labeler based in Columbus, OH. The image shows multiple identical labels arranged in rows.*

FDA Label Image

20 mg Lurasidone Hydrochloride Tablets Carton (20 mg Carton)

Label for Lurasidone Hydrochloride 20 mg film-coated tablets, oral route. The label displays the product name, strength of 20 mg, and quantity of 30 tablets (3 x 10). It includes barcode, storage instructions, pharmacist dispensing information, and distributor details: American Health Packaging, Columbus, Ohio.*

FDA Label Image

40 mg Lurasidone Hydrochloride Tablet Blister (40 mg Blister)

Labels for Lurasidone Hydrochloride 40 mg film-coated tablets, oral dosage form. Each label includes the drug name, strength, lot number placeholder, expiration date placeholder, American Health Packaging as the labeler, and a barcode. Multiple identical labels are shown in a sheet format.*

FDA Label Image

40 mg Lurasidone Hydrochloride Tablets Carton (40 mg Carton)

Lurasidone Hydrochloride 40 mg film-coated tablets label showing package size of 30 tablets (3 x 10) by American Health Packaging. The label includes NDC number 60687-758-21, barcode, pharmacist instructions, storage conditions, dosage strength, and distribution information from Columbus, Ohio.*

FDA Label Image

60 mg Lurasidone Hydrochloride Tablet Blister (60 mg Blister)

Labels for Lurasidone Hydrochloride 60 mg film-coated tablets, oral route. Each label displays the generic drug name, dosage strength, lot number placeholder, expiration date placeholder, and barcode. The labels indicate they are manufactured by American Health Packaging in Carol Stream, IL.*

FDA Label Image

60 mg Lurasidone Hydrochloride Tablets Carton (60 mg Carton)

Packaging label for Lurasidone Hydrochloride 60 mg film-coated tablets. The label indicates a count of 20 tablets (2 x 10) and states the product is prescription only. The labeler is American Health Packaging. Additional instructions and storage information are included on the label.*

FDA Label Image

Ahp74721

Lurasidone Hydrochloride 20 mg film-coated tablet shown front and back. The round white tablet is imprinted with 'L 20' on one side and is plain on the other, displayed next to a millimeter scale for size reference. Manufactured by American Health Packaging.*

FDA Label Image

Ahp75821

Lurasidone Hydrochloride 40 mg film-coated oral tablet. The tablet is round, white, with 'L' and '40' debossed on one side and a plain reverse side. Labeler is American Health Packaging.*

FDA Label Image

Ahp76994

Lurasidone Hydrochloride 60 mg film-coated oral tablet imprinted with 'L 60'. The white, oblong tablet is designed for oral use. Labeler: American Health Packaging.*

FDA Label Image

Figure 1: Impact Of Other Drugs On Lurasidone Hydrochloride Tablets Pharmacokinetics (Figure1)

A chart showing the impact of various interacting drugs on the pharmacokinetics (PK) of Lurasidone Hydrochloride. The graph displays fold changes and 90% confidence intervals for Cmax and AUC relative to lurasidone alone, with interacting drugs categorized as strong or moderate CYP3A4 inhibitors or inducers, including ketoconazole, diltiazem, rifampin, and lithium.*

FDA Label Image

Figure 2: Impact Of Lurasidone Hydrochloride Tablets On Other Drugs (Figure2)

A pharmacokinetic interaction chart for Lurasidone Hydrochloride showing fold changes and 90% confidence intervals in drug exposure. The graph compares Cmax, AUC, and trough levels for drugs including Digoxin, Midazolam, Ethinyl Estradiol, Norelgestromin, and Lithium relative to each drug alone.*

FDA Label Image

Figure 3: Impact Of Other Patient Factors On Lurasidone Hydrochloride Tablets Pharmacokinetics (Figure4)

A chart depicting fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of Lurasidone Hydrochloride in populations with varying degrees of renal and hepatic impairment, as well as by gender and race. The horizontal axis represents change relative to reference values, with points and error bars illustrating variability.*

FDA Label Image

Structural Formula (Structure)

Chemical structure of Lurasidone Hydrochloride, showing its molecular framework including rings and heteroatoms with a hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.